TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/11/24 17:46 | 9/9/24 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Kelly Paul Edward | FL | D | P | 65 | 2.59 | 0 | 25 | 13 | 212 | D | |||||||||||||||
10/21/19 16:07 | 10/18/19 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Kelly Paul Edward | NY | D | P | 96 | 19.14 | 0 | 5 | 4 | 127 | D | |||||||||||||||
5/15/19 16:07 | 5/14/19 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Kelly Paul Edward | NY | D | P.d | 150 | 1.50 | 0 | 100 | 26 | 488 | D | |||||||||||||||
12/11/18 16:21 | 12/11/18 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Kelly Paul Edward | NY | D | P | 6 | 1.21 | 0 | 5 | 1 | 388 | D | |||||||||||||||
10/19/18 13:02 | 10/12/18 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Kelly Paul Edward | NY | D | P.d | 135 | 0.9000 | 0 | 150 | 64 | 383 | D | |||||||||||||||
12/16/15 16:27 | 12/14/15 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Kelly Paul Edward | NY | D | P | 29 | 2.91 | 0 | 10 | New | 10 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |